Literature DB >> 19955307

Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Shawn D Blackburn1, Alison Crawford, Haina Shin, Antonio Polley, Gordon J Freeman, E John Wherry.   

Abstract

The PD-1/PD-L pathway plays a major role in regulating T-cell exhaustion during chronic viral infections in animal models, as well as in humans, and blockade of this pathway can revive exhausted CD8(+) T cells. We examined the expression of PD-1 and its ligands, PD-L1 and PD-L2, in multiple tissues during the course of chronic viral infection and determined how the amount of PD-1 expressed, as well as the anatomical location, influenced the function of exhausted CD8 T cells. The amount of PD-1 on exhausted CD8 T cells from different anatomical locations did not always correlate with infectious virus but did reflect viral antigen in some tissues. Moreover, lower expression of PD-L1 in some locations, such as the bone marrow, favored the survival of PD-1(Hi) exhausted CD8 T cells, suggesting that some anatomical sites might provide a survival niche for subpopulations of exhausted CD8 T cells. Tissue-specific differences in the function of exhausted CD8 T cells were also observed. However, while cytokine production did not strictly correlate with the amount of PD-1 expressed by exhausted CD8 T cells from different tissues, the ability to degranulate and kill were tightly linked to PD-1 expression regardless of the anatomical location. These observations have implications for human chronic infections and for therapeutic interventions based on blockade of the PD-1 pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955307      PMCID: PMC2812396          DOI: 10.1128/JVI.01579-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination.

Authors:  E John Wherry; Joseph N Blattman; Rafi Ahmed
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Protein analysis of defective interfering lymphocytic choriomeningitis virus and persistently infected cells.

Authors:  R M Welsh; M J Buchmeier
Journal:  Virology       Date:  1979-07-30       Impact factor: 3.616

3.  Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV).

Authors:  M Rodriguez; M J Buchmeier; M B Oldstone; P W Lampert
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

4.  Restricted expression of viral glycoprotein in cells of persistently infected mice.

Authors:  M B Oldstone; M J Buchmeier
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

5.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

6.  Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.

Authors:  X S He; B Rehermann; F X López-Labrador; J Boisvert; R Cheung; J Mumm; H Wedemeyer; M Berenguer; T L Wright; M M Davis; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Authors:  Ian F Hermans; Jonathan D Silk; Jianping Yang; Michael J Palmowski; Uzi Gileadi; Corinna McCarthy; Mariolina Salio; Franca Ronchese; Vincenzo Cerundolo
Journal:  J Immunol Methods       Date:  2004-02-01       Impact factor: 2.303

8.  HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.

Authors:  Christoph Hess; Marcus Altfeld; Seddon Y Thomas; Marylyn M Addo; Eric S Rosenberg; Todd M Allen; Rika Draenert; Robert L Eldrige; Jan van Lunzen; Hans-J Stellbrink; Bruce D Walker; Andrew D Luster
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

9.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

10.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.

Authors:  R Ahmed; A Salmi; L D Butler; J M Chiller; M B Oldstone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  69 in total

1.  Genomic analysis and pathogenic characteristics of lymphocytic choriomeningitis virus strains isolated in Japan.

Authors:  Toshikazu Takagi; Makiko Ohsawa; Chiharu Morita; Hiroshi Sato; Kazutaka Ohsawa
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

2.  PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.

Authors:  Wen Xiao; Long Feng Jiang; Xiao Zhao Deng; Dan Yan Zhu; Jia Ping Pei; Mao Lei Xu; Bing Jun Li; Chang Jun Wang; Jing Hai Zhang; Qi Zhang; Zhen Xian Zhou; Wei Liang Ding; Xiao Dong Xu; Ming Yue
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 3.  Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response.

Authors:  Michael B A Oldstone; Kevin P Campbell
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

4.  CD8+ memory T cells appear exhausted within hours of acute virus infection.

Authors:  Martin P Hosking; Claudia T Flynn; Jason Botten; J Lindsay Whitton
Journal:  J Immunol       Date:  2013-09-11       Impact factor: 5.422

5.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

Review 6.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

7.  Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.

Authors:  Filippos Porichis; Douglas S Kwon; Jennifer Zupkosky; Daniel P Tighe; Ashley McMullen; Mark A Brockman; David F Pavlik; Marta Rodriguez-Garcia; Florencia Pereyra; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

8.  Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.

Authors:  Hyun-Tak Jin; Ana C Anderson; Wendy G Tan; Erin E West; Sang-Jun Ha; Koichi Araki; Gordon J Freeman; Vijay K Kuchroo; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

9.  Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model.

Authors:  Fabienne McClanahan; John C Riches; Shaun Miller; William P Day; Eleni Kotsiou; Donna Neuberg; Carlo M Croce; Melania Capasso; John G Gribben
Journal:  Blood       Date:  2015-05-15       Impact factor: 22.113

10.  PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

Authors:  Benjamin A Kansy; Fernando Concha-Benavente; Raghvendra M Srivastava; Hyun-Bae Jie; Gulidanna Shayan; Yu Lei; Jessica Moskovitz; Jennifer Moy; Jing Li; Sven Brandau; Stephan Lang; Nicole C Schmitt; Gordon J Freeman; William E Gooding; David A Clump; Robert L Ferris
Journal:  Cancer Res       Date:  2017-09-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.